InsidersTradesSigma
尚无足够的、已确定 T+90 期限的买入信号来衡量交易记录。
Explore the full record of transactions filed by White Christopher G, Directeur commercial. Director active across 2 companies, notably OCULAR THERAPEUTIX, INC. In total, 5 disclosures have been recorded. Split: 0 buy · 2 sells. Total volume traded: €46k. History available since 3 February 2022. The latest transaction was disclosed on 3 February 2024 (Attribution). Regulator: SEC (Form 4). All data is openly available.
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
5 条申报中的 5 条
Christopher G. White is the Chief Business Officer at Ocular Therapeutix, Inc. He is responsible for business strategy and development. His experience in the biopharmaceutical sector is an asset in guiding Ocular Therapeutix in its growth initiatives.